We are live on ! Find out more
ACA

Avoro Capital Advisors Portfolio holdings

AUM $10.2B
1-Year Est. Return 149.19%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+149.19%
3 Year Est. Return
+425.03%
5 Year Est. Return
+775.33%
10 Year Est. Return
+45,729.2%
AUM
$2.18B
AUM Growth
-$420M
Cap. Flow
-$342M
Cap. Flow %
-15.71%
Top 10 Hldgs %
69.34%
Holding
52
New
10
Increased
7
Reduced
16
Closed
7

Top Buys

Rank Stock Value
1
TCDA
Tricida, Inc. Common Stock
TCDA
+$19.8M
2
AMRN
Amarin Corp
AMRN
+$15.3M
3
XENE icon
Xenon Pharmaceuticals
XENE
+$13.5M
4
ESTA icon
Establishment Labs
ESTA
+$12.2M
5
YMAB
Y-mAbs Therapeutics
YMAB
+$7.88M

Top Sells

Rank Stock Value
1
SPPI
Spectrum Pharmaceuticals Inc
SPPI
+$71.7M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$69M
3
PTCT icon
PTC Therapeutics
PTCT
+$66.7M
4
VNDA icon
Vanda Pharmaceuticals
VNDA
+$48.4M
5
PCRX icon
Pacira BioSciences
PCRX
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 82.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDCO
51
DELISTED
Medicines Co
MDCO
– –
-961,574
Closed -$35.3M
1 2
3

Similar funds

IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Avoro Capital Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Avoro Capital Advisors held 52 positions worth $2.18B, down 16% from $2.6B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Avoro Capital Advisors withdrew a net $342M in Q3 2018, closing 7 positions and reducing 16 holdings. Its most notable exit was Spectrum Pharmaceuticals Inc, an estimated $71.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, up from 82% a quarter earlier.

Against the trend, Avoro Capital Advisors opened a new position in Amarin Corp worth $65.8M.

  • Avoro Capital Advisors's largest Q3 2018 buy was Amarin Corp: 202,250 shares worth $65.8M.
  • Avoro Capital Advisors added most to Tricida, Inc. Common Stock in Q3 2018, an estimated $19.8M increase.
  • Avoro Capital Advisors's biggest Q3 2018 reduction was PTC Therapeutics, cutting an estimated $66.7M.
  • Avoro Capital Advisors fully exited Spectrum Pharmaceuticals Inc in Q3 2018, selling an estimated $71.7M.
  • Avoro Capital Advisors's ten largest holdings make up 69% of its $2.18B portfolio in Q3 2018.
  • Avoro Capital Advisors opened 10 new positions and closed 7 in Q3 2018.
  • Avoro Capital Advisors's portfolio value fell 16% quarter-over-quarter to $2.18B.

Based on Avoro Capital Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.